Werbung
Werbung
BRNS
Barinthus Biotherapeutics plc - ADR
0.76
USDGesponsert
0.00
+0.28%
09. Jan., 12:28 UTC -5
Geschlossen
Nach-Markt
0.74
-0.02
-2.24%
BRNS Ergebnisberichte
Positives Überraschungsverhältnis
BRNS übertreffen die 12 der letzten 19Schätzungen.
63%
Nächster Bericht
Datum des nächsten Berichts
18. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.40
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/+66.67%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/-21.57%
Barinthus Biotherapeutics plc - ADR earnings per share and revenue
On 07. Nov. 2025, BRNS reported earnings of -0.24 USD per share (EPS) for Q3 25, beating the estimate of -0.45 USD, resulting in a 47.71% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -10.08% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.40 USD, with revenue projected to reach -- USD, implying an increase of 66.67% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were Barinthus Biotherapeutics plc - ADR's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Barinthus Biotherapeutics plc - ADR reported EPS of -$0.24, beating estimates by 47.71%, and revenue of $0.00, 0% as expectations.
How did the market react to Barinthus Biotherapeutics plc - ADR's Q3 2025 earnings?
The stock price moved down -10.08%, changed from $1.19 before the earnings release to $1.07 the day after.
When is Barinthus Biotherapeutics plc - ADR expected to report next?
The next earning report is scheduled for 18. März 2026.
What are the forecasts for Barinthus Biotherapeutics plc - ADR's next earnings report?
Based on 4
analysts, Barinthus Biotherapeutics plc - ADR is expected to report EPS of -$0.40 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung